16
Link wasn't entirely sure what the Raiders' fighter jets were called, but their main wings extended outwards, each then branching into three smaller wings.
There were two thrusters beneath the main wings, a propulsion system at the rear, and additional thrusters on the smaller wings, giving them exceptional maneuverability due to the numerous power outlets.
Link could entirely base his flying board design on this concept, though without a control stick, it would require AI assistance for flight.
This was also good, providing a reference for future spaceship construction; these Raiders' fighter jets actually resembled swallows in overall shape, so basing his flying board on the swallow's form would be justifiable.
Link quickly immersed himself in the research!
The next day, Jessica went to remind Norman Osborn and Wilson Fisk to keep an eye on the cured patients and not allow them to leave immediately.
They needed to undergo an observation period and also return for regular check-ups, though regular check-ups would likely be difficult, and they might even come back to you if they got sick again in the future.
However, everyone took it seriously, especially Matthew Murdock; although he sympathized with these poor people, the contract had already been signed, and if these individuals escaped, it would be a breach of contract.
Leaving aside Norman Osborn, Wilson Fisk alone was not someone to trifle with.
If he were truly angered, people would simply disappear; that guy would absolutely kill.
Therefore, Matthew Murdock began to visit the hospital constantly, using the pretext of inquiring about treatment procedures to repeatedly reiterate the legal responsibilities of both parties.
Under these circumstances, the first phase of treatment concluded, and as observation continued, the cured patients passed their observation period and gradually began to be discharged.
Audiences who had been following the program were full of anticipation for the special medicine, and there were many calls for its immediate market release, while Osborn Group's stock price began to rise steadily.
Many shareholders were seeking to buy shares, but none were available on the stock market for the time being; Link and Norman Osborn had previously acquired many, and they couldn't hold onto them indefinitely.
After all, there are requirements for circulating shares; Osborn Group's situation had nearly led to bankruptcy before, so they could wait for a while, but not for too long.
Link decided to release ten million shares into the stock market first, but not all at once; instead, he would gradually increase the price.
Releasing them all at once would result in a loss, so they needed to be released slowly, allowing the circulating shares to gradually flow back into the market.
...
The second phase began with the same procedures; after completing the patient records, treatment commenced, while a few first-phase patients returned to the hospital for regular check-ups.
Under these circumstances, by the end of the third phase, it was already late 2010, and Link had finalized the design of the flying board.
New York was covered in heavy snow, Osborn Group's stock price surpassed the one hundred billion mark, and over a dozen special medicines began production and accepted orders; their primary focus was not the United States, but rather abroad.
Especially in the great Eastern nation, they exported at low prices; even with added taxes, the price was not expensive, and Link actively pushed for its inclusion in the medical insurance system.
This would make the price even more affordable; Link was aiming for high volume with low profit margins, and the acquired building was already complete, so Link and Norman Osborn decided to move immediately.
At the same time, the original Osborn Group Building was put up for sale, with the proceeds used to repay Link.
The top floor of the new building was not entirely open like Tony Stark's; the outdoor balcony was similar to a helipad, but the interior had distinct styles.
The living room, kitchen, and dining room were completely open, but it also featured a study, bedrooms, guest rooms, bathrooms, and other residential functions.
The floor below was an automated factory, which was completely enclosed, with only one staircase serving as an entrance, requiring access from the top floor; all elevators bypassed this level.
Link didn't need to build Iron Man armor; he only needed to build flying boards and combat suits; he had been designing during this period, and the flying board was progressing smoothly; he even obtained a cold fusion reactor built with a new element provided by Tony Stark.
Additionally, Link had completed the design for nanotechnology, and he suddenly realized that with nanotechnology, why would he still wear a tight-fitting combat suit?
He didn't fight with his fists but with weapons, guns and throwing knives, so there was no need to be confined to Superman's attire.
New inspiration struck, but Link first completed the relocation of the group headquarters; the entire upper section was dedicated to laboratories, an area Link was responsible for.
Link began to examine all research projects; he quickly selected those with a chance of success, then formed them into research teams and allocated laboratories.
Projects with no visible hope, or those with incorrect research directions, were directly canceled, and he would then assign tasks.
Of course, this was done secretly, with Norman Osborn acting as an intermediary; so why didn't Link appear himself or conduct the research personally?
On one hand, it was for secrecy; Link didn't want to expose himself too early, as this matter sounded reliable and could easily lead to suspicion.
On the other hand, Osborn Group was currently making a big splash; with the sale of medicines, more and more patients were being cured, and Osborn Group's stock price continued to climb, directly reaching two hundred billion U.S. dollars, making it the highest-valued pharmaceutical group.
However, this stock value was already quite good; Link then immediately contacted Pepper Potts, and Stark Industries' weapons division was merged into Osborn Group, with Stark Industries taking a stake in return.
However, this weapons division only included production factories and research laboratories, not the weapons previously developed by Stark Industries.
The production rights for these weapons were in the Military's hands; otherwise, the price wouldn't be this; Stark Industries held twenty percent of Osborn Group's shares, valued at forty billion U.S. dollars.
Link's portion was reduced to fifty-two percent, Norman Osborn held twenty percent, and the remaining eight percent entered the stock market as circulating shares.
For now, the equity structure was like this; if more shareholders were to join later, it would need to be discussed, and Link would not reduce his shares again.
The weapon research department had already been downsized because Tony Stark had closed it, leading to a large loss of research personnel, but the laboratories and equipment remained.
The production department was temporarily intact, and Norman Osborn lobbied the Military, securing some production quotas; the Military also hoped to maintain these weapon production factories, as they were equipped with top-tier equipment and workers.
After Link handled these matters, he finally began the final refinement.
